Showing 2,241 - 2,260 results of 44,189 for search '"In Treatment"', query time: 0.13s Refine Results
  1. 2241
  2. 2242
  3. 2243

    Antibiotic Susceptibility Profile of Aeromonas Species Isolated from Wastewater Treatment Plant by Isoken H. Igbinosa, Anthony I. Okoh

    Published 2012-01-01
    “…This study assessed the prevalence of antibiotic-resistant Aeromonas species isolated from Alice and Fort Beaufort wastewater treatment plant in the Eastern Cape Province of South Africa. …”
    Get full text
    Article
  4. 2244

    Cost-effectiveness of Ruxolitinib vs Best Available Therapy in the Treatment of Myelofibrosis in Spain by María Teresa Gómez-Casares, Juan Carlos Hernández-Boluda, Antonio Jiménez-Velasco, Joaquin Martínez-López, María Giovanna Ferrario, Irmina Gozalbo, Joana Gostkorzewicz, Rudi Subirá

    Published 2017-11-01
    “…Ruxolitinib is the first JAK1/JAK2 inhibitor specifically approved for the treatment of disease-related splenomegaly or symptoms in adult patients with primary myelofibrosis. …”
    Get full text
    Article
  5. 2245

    Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta-Analysis by Dong Wu, Shu-Mei Wu, Jie Lu, Ying-Qun Zhou, Ling Xu, Chuan-Yong Guo

    Published 2013-01-01
    “…Many studies have found that the antibiotic rifaximin is effective for the treatment of hepatic encephalopathy. However, there is no uniform view on the efficacy and safety of rifaximin. …”
    Get full text
    Article
  6. 2246
  7. 2247

    Effect of Doping Phosphorescent Material and Annealing Treatment on the Performance of Polymer Solar Cells by Zixuan Wang, Fujun Zhang

    Published 2013-01-01
    “…The power conversion efficiency (PCE) of PSCs with P3HT:PCBM as the active layer is increased from 0.19% to 1.49% by annealing treatment at 140°C for 10 minutes. The PCE of PSCs with P3HT:PCBM:Ir(btpy)3 as the active layer is increased from 0.49% to 0.95% by annealing treatment at lower temperature at 100°C for 10 minutes.…”
    Get full text
    Article
  8. 2248
  9. 2249
  10. 2250

    Cannabinoids and Their Role in Chronic Pain Treatment: Current Concepts and a Comprehensive Review by Islam Shehata, Ahmed Hashim, Ahmed Saad Elsaeidy, Anagha Nair, Ivan Urits, Omar Viswanath, Alan D. Kaye, Marian Habib

    Published 2022-10-01
    “…These different approaches carry many pharmacological hazards together with the lack of efficacy and safety of many interventional and surgical management techniques for chronic pain have mandated searching for other effective therapies including alternative treatments. Cannabinoids are naturally occurring substances that are derived from Cannabis sativa L. …”
    Get full text
    Article
  11. 2251

    Postphlebitic ulcer treatment with platelet-rich plasma and autograft of skin. Case Presentation by Eldis Sánchez Consuegra, Julio Dámaso Fernández Águila, Nancy Soraya Izaguirre Hernández

    Published 2017-06-01
    “…She was suffering from a large post - phlebitic ulcer (14 x 9 cm) with a long evolution in the right maleolotibial region. It was applied a treatment with autologous plasma gel rich in platelets and then autografting skin free, of medium thickness. …”
    Get full text
    Article
  12. 2252

    Non-enzymatic protein targeting agents as a promising strategy for cancer treatment by Madison Ambrose, Jeremy Lee, Aleem Syed, Zamal Ahmed, Guang Peng

    Published 2025-01-01
    “…Increased research attention has been brought to non-enzymatic protein targeting agents as a new and effective strategy for advancing cancer treatment. To discover this class of new anticancer drugs, two molecular approaches targeting the non-enzymatic activities of proteins have shown promising experimental, preclinical, and clinical results. …”
    Get full text
    Article
  13. 2253

    A systematic review of the Novosorb® Biodegradable Temporizing Matrix in the treatment of complex wounds by Olivia Fruergaard, Mathias Ørholt, Christian Lyngsaa Lang, Jennifer Berg Drejøe, Mikkel Herly, Peter Vester-Glowinski, David Hebbelstrup Jensen

    Published 2025-01-01
    “…The purpose of this systematic review is to assess the efficacy, advantages and limitations of employing NovoSorb® Biodegradable Temporizing Matrix (BTM) in the treatment of complex wounds. Methods: The systematic review was carried out in accordance with PRISMA and MOOSE guidelines when appropriate. …”
    Get full text
    Article
  14. 2254
  15. 2255
  16. 2256
  17. 2257

    Computational screening, synthesis and neuroprotective evaluation of small molecule for the treatment of alzheimer's disease by Nerlis Pajaro-Castro, Elkin Torres-Sierra, Edwar Cortes-Gonzalez, Margaret Paternina, Erwin Camacho, Pedro Blanco

    Published 2024-12-01
    “… BACKGROUND: Current treatments for Alzheimer’s disease primarily address symptoms, as no definitive therapeutic targets have been identified. …”
    Get full text
    Article
  18. 2258
  19. 2259

    Investigating the Efficacy of an Individualized Alpha/Delta Neurofeedback Protocol in the Treatment of Chronic Tinnitus by Dominik Güntensperger, Christian Thüring, Tobias Kleinjung, Patrick Neff, Martin Meyer

    Published 2019-01-01
    “…First attempts have demonstrated that the application of alpha/delta neurofeedback in the treatment of chronic tinnitus leads to a reduction of symptoms at the group level. …”
    Get full text
    Article
  20. 2260

    An orally administered gold nanocluster with ROS scavenging for inflammatory bowel disease treatment by Fei Wang, Qianhui Li, Tingting Xu, Zhu Li, Yongxin Jiang, Yan Ma, Xiaohu Li, Wanni Wang, Haisheng Qian

    Published 2025-01-01
    “…Au25 NCs can eliminate ROS such as ABTS radicals, superoxide free radicals (•O2−), and hydroxyl free radicals (•OH), upregulate the expression level of antioxidant enzymes, inhibit the expression of proinflammatory cytokines, and finally interrupt the inflammatory circuit of IBD to achieve the effective prevention and delayed treatment of IBD. This work will demonstrate the protective effect of Au25 NCs on IBD in living animals, which suggests a new nanomedicine strategy for IBD treatment.…”
    Get full text
    Article